Skip to main content

GOLDMAN SACHS GROUP INC

Position in INBX — Inhibrx Biosciences, Inc.

CIK 886982 NEW YORK, NY

Position in INBX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$32,042,176
+$25,650,352 QoQ
Shares Held
338,176
+255.7% QoQ
Ownership
2.30%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 161 holders
Holding Since
Sep 2024
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INBX Over Time

Shares Held

Position Value (USD)

Derivatives in INBX

reported options exposure · as of Jun 30, 2026
CallValue
$6,300,875
CallShares
66,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. INBX ranks #90 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in INBX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $32,042,176 338,176
2026-06-30 $6,300,875 66,500
2026-03-31 $6,391,824 95,074
2026-03-31 $4,470,795 66,500
2025-09-30 $874,534 25,966
2025-06-30 $158,240 11,089
2024-12-31 $884,683 57,447
2024-09-30 $340,792 21,762